Atezolizumab Induced Sicca Syndrome: A Case Report
Aiswarya Wilson, Vidya S, Siby Joseph, Madhu C S, Aditya V Boney
International Journal of Medical and Pharmaceutical Case Reports · pp. 1–5 · Published 20 Mar 2025
10.9734/ijmpcr/2025/v18i2414Abstract
Immune checkpoint inhibitors have made a drastic improvement in the management of cancer though it is not completely free from adverse outcomes, which may be due to the dysregulated immune system. These negative outcomes following treatment with checkpoint inhibitors are collectively known as immune related adverse events. Though there are many case reports of sicca syndrome induced by immune checkpoint inhibitors, Atezolizumab was free from this adverse outcome. In our patient care setting we observed sicca syndrome in one elderly patient during treatment with Atezolizumab. It was managed with corticosteroids; pilocarpine eye drops and other standard care of treatment.
Cited by 0
No indexed citations yet.
Related research
- Advancing Glioblastoma Treatment: Challenges and Opportunities of Immune Checkpoint Inhibition — shares topic coverage
- Accessibility and Inclusivity of Chimeric Antigen Receptor T-cell Immunotherapy in Treating Hematological Malignancies — shares topic coverage
- Immune-Related Adverse Events of Checkpoint Inhibitors: Clinical Spectrum and Insights Across Major Malignancies — shares topic coverage
- Immunotherapy Strategies for Overcoming Resistant Cancers: Current Trends and Future Prospects — shares topic coverage
- Targeted and Immunotherapeutic Approaches in Cancer: A Narrative Review of Evolving Evidence and Clinical Implications — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.